News | February 27, 2015

Medical 3-D Printing Purchases to Eclipse 2,000 by 2020

Modeling, surgical guides among uses driving high demand

3-D printing, medical industry, advanced visualization, 2020

February 27, 2015 — In a new report, SmarTech Markets Publishing forecasts shipments of 3-D printers in the medical industry will reach 2,135 units in 2020, growing to 3,055 units in 2024. The report, "3-D Printing in Medical Markets: An Opportunity Analysis and Ten-Year Forecast," shows where opportunities will be found.

The report includes 10-year forecasts with breakouts by printer technology, materials type and software expenditures. It also contains market analysis for a wide variety of medical applications including implants, surgical tools and guides, medical models, medical devices and equipment prototyping. The report further discusses where 3-D printing must adapt to meet the needs of medicine. Comprehensive profiles of medical related strategies of 15 leading 3-D printer firms are included.

Companies discussed in the report include: 3-D Systems, Arcam, Autodesk, Bespoke Innovations, e-Nable, EnvisionTEC, EOS, Innovation MediTech, Lima Corporate, LUXeXcel, Medical Modeling, Optomec, Organovo, Ossis, Oxford Performance Materials, Protos Eyewear, Rapid Shape, Renishaw, Stratasys, Visualization Sciences, voxeljet, Within Technologies and Worrell.

In 2014 just over 1,100 printers were sold for medical applications, more than 60 percent falling into the photopolymerization or material jetting categories. Both these types of medical 3-D printers can handle modeling, surgical guides and tools, medical prototypes and hearing aid shells. They are not suitable for implants and prosthetics, where requirements are highly specific. By 2020, shipments of medical 3-D printers are expected to have almost doubled.

Revenues of materials for medical 3-D printing were almost $50 million in 2014 and are expected to reach $345 million by 2020. After 2020 revenues from 3-D printed medical materials will be larger that revenues from the printers themselves. SmarTech's bullish forecast for materials is due to rapidly increasing print volumes for medical applications. Primary drivers for these increased volumes are medical models and orthopedic implants. Currently, most of the sales of 3-D printed materials for medical applications are photopolymers and metal powders.

For more information: www.smartechpublishing.com

Related Content

RSNA and ACR to Collaborate on Landmark Medical 3D Printing Registry
News | Medical 3-D Printing | August 08, 2019
The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
TeraRecon Unveils iNtuition AI Data Extractor
News | Advanced Visualization | July 03, 2019
Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor...
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
TeraRecon Receives FDA Clearance for Northstar AI Results Explorer
Technology | Artificial Intelligence | June 20, 2019
Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S...
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Medivis SurgicalAR Gets FDA Clearance
Technology | Virtual and Augmented Reality | June 10, 2019
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has...
Ann Arbor Startup Launches Augmented Reality MRI Simulator
Technology | Virtual and Augmented Reality | June 04, 2019
SpellBound, an Ann Arbor startup specializing in augmented reality (AR) tools for children in hospitals, has officially...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res